BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2797378)

  • 1. SSPE-epidemiology and measles vaccination: our cases.
    Vucenović V; Vranjesević D
    Neurologija; 1989; 38(1):23-31. PubMed ID: 2797378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
    Enders-Ruckle G
    Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subacute sclerosing panencephalitis in Bulgaria (1978-2002).
    Bojinova V; Dimova P; Belopitova L; Mihailov A; Gatcheva N; Mihneva Z; Todorova M
    Neuroepidemiology; 2004; 23(5):254-7. PubMed ID: 15316253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.
    Modlin JF; Jabbour JT; Witte JJ; Halsey NA
    Pediatrics; 1977 Apr; 59(4):505-12. PubMed ID: 850592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
    Zilber N; Rannon L; Alter M; Kahana E
    Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subacute sclerosing panencephalitis in Wales.
    Sussman J; Compston DA
    Q J Med; 1994 Jan; 87(1):23-34. PubMed ID: 8140214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
    J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era.
    Sonia M; Lalit D; Shobha B; Sheffali G; Amandeep S; Veena K; Madhuri B
    J Commun Dis; 2009 Sep; 41(3):161-7. PubMed ID: 22010482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.
    Miller C; Andrews N; Rush M; Munro H; Jin L; Miller E
    Arch Dis Child; 2004 Dec; 89(12):1145-8. PubMed ID: 15557053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiological study of subacute sclerosing panencephalitis in Japan, 1976.
    Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Sato T; Isomura S; Ueda S; Kitamura I; Kaji M
    Biken J; 1978 Mar; 21(A):9-14. PubMed ID: 666722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the effect of measles vaccination on the epidemiology of SSPE.
    Campbell H; Andrews N; Brown KE; Miller E
    Int J Epidemiol; 2007 Dec; 36(6):1334-48. PubMed ID: 18037676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subacute sclerosing panencephalitis (SSPE) in Poland 1984-1986. Stage III of epidemiologic studies].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska B; Kulczycki J; Gut W
    Przegl Epidemiol; 1988; 42(3):205-10. PubMed ID: 3254552
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of the correlation between measles and subacute sclerosis panencephalitis (SSPE) before and after introduction of vaccination in Poland].
    Gut W; Naruszewicz-Lesiuk D
    Przegl Epidemiol; 1992; 46(4):295-301. PubMed ID: 1305779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of clinical course of subacute sclerosing panencephalitis: experience at the Children's Hospital, Lahore.
    Malik MA; Saeed M; Qureshi AU; Ahmed N; Akram M
    J Coll Physicians Surg Pak; 2010 Oct; 20(10):671-4. PubMed ID: 20943110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological aspects of SSPE].
    Nihei K
    Nihon Rinsho; 2007 Aug; 65(8):1460-5. PubMed ID: 17695284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subacute sclerosing panencephalitis: fulminant form].
    Grippo J; Cáceres L; Asís A; Grippo T; Ruprecht B; López M
    Rev Neurol; 2003 Mar 16-31; 36(6):536-9. PubMed ID: 12652417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles vaccination and risk of SSPE.
    Agarwal RK
    Indian Pediatr; 1999 Mar; 36(3):317. PubMed ID: 10713848
    [No Abstract]   [Full Text] [Related]  

  • 18. Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated.
    Wendorf KA; Winter K; Zipprich J; Schechter R; Hacker JK; Preas C; Cherry JD; Glaser C; Harriman K
    Clin Infect Dis; 2017 Jul; 65(2):226-232. PubMed ID: 28387784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further epidemiological investigations on subacute sclerosing panencephalitis (SSPE) in Romania.
    Cernescu C; Milea S
    Virologie; 1980; 31(3):173-82. PubMed ID: 6254241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.
    Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Fukuyama Y; Sato T; Isomura S; Ueda S; Kitamura I
    Int J Epidemiol; 1989 Sep; 18(3):684-9. PubMed ID: 2807674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.